Background Despite the increasing knowledge of the etiology of neuropathic pain, this type
of chronic pain is resistant to available analgesics in approximately 50% of patients and …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, debilitating, and dose-
limiting side effect of many chemotherapy regimens yet has limited treatments due to …

Trigeminal neuropathic pain is a chronic pain condition caused by damage or inflammation
of the trigeminal nerve or its branches, with both peripheral and central nervous system …

Alteration in gene expression along the pain signaling pathway is a key mechanism
contributing to the genesis of neuropathic pain. Accumulating studies have shown that …

This review summarizes the adverse effects on the central and/or peripheral nervous
systems that may occur in response to antineoplastic drugs. In particular, we describe the …

Pain, although unpleasant, is an essential warning mechanism against injury and damage
of the organism. An intricate network of specialised sensors and transmission systems …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a painful condition,
experienced by patients undergoing chemotherapy with some specific drugs, such as …

Neuropathic pain is a debilitating pathological condition that is poorly understood. Recent
evidence suggests that abnormal central processing occurs during the development of …

Chemotherapy‐induced neuropathy (CIN) is a common complication of cancer treatment.
Although CIN is treated with antidepressants that act at serotonin (5‐HT) reuptake, the …

Chemotherapy is widely used as a primary treatment or adjuvant therapy for cancer. Anti-
microtubule agents (such as paclitaxel and docetaxel) are used for treating many types of …